Bank of New York Mellon
GCVRZ

Bank of New York Mellon’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bank of New York Mellon’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-19,274
Closed -$8K – 4522
2017
Q4 		$8K Sell
19,274
-2,855
-13% -$1.08K ﹤0.01% 4341
2017
Q3 		$8K Buy
22,129
+12,083
+120% +$4.47K ﹤0.01% 4250
2017
Q2 		$4K Buy
+10,046
New +$4.1K ﹤0.01% 4290
2013
Q4 		– Sell
-10,522
Closed -$21K – 4340
2013
Q3 		$21K Buy
+10,522
New +$20K ﹤0.01% 4116

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.21% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.82% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return

Bank of New York Mellon's GCVRZ Position: Q1 2018 in Review

Bank of New York Mellon sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2018, closing a stake of 19,274 shares — an estimated $8K sold.

Bank of New York Mellon first reported a position in GCVRZ in Q3 2013 and held it in 4 quarters. The position peaked at $21K in Q3 2013. 100 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2018.

  • Bank of New York Mellon reported no remaining Sanofi Contingent Value Rights position as of Q1 2018 after selling out during the quarter.
  • Bank of New York Mellon sold 19,274 Sanofi Contingent Value Rights shares in Q1 2018, an estimated $8K.
  • Bank of New York Mellon first reported a position in Sanofi Contingent Value Rights in Q3 2013 and held it in 4 quarters.
  • Bank of New York Mellon's Sanofi Contingent Value Rights position peaked at $21K in Q3 2013.
  • 100 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2018.

Based on Bank of New York Mellon's 13F filing for Q1 2018, filed 15 May 2018.